期刊文献+

降压治疗中的J形曲线:临床证据带来的困惑和启示 被引量:2

The J-curve in antihypertensive treatment
暂未订购
导出
摘要 在高血压的循证治疗中,始终存在着相矛盾的临床证据。人群调查显示,血压越低心血管病危险越少。因此,不少学者坚信,在患者耐受的情况下,应力争最大限度地降低血压。也有一些临床研究证实,血压降到一定程度后,反而增加心血管事件的危险,出现所谓的J形曲线。本文回顾性综述上述两种观点近几年的临床研究证据,为正确认识这些研究结果,制定科学合理的血压管理策略提供依据。 In antihypertensive treatment, sometimes the clinical evidence conflicts each other. Some investigation data showed the lower blood pressure the lower risk of cardiovascular disease. However, the other clinical data confirmed that the risk of cardiovascular disease could increase when blood pressure declines to certain degree which is so-called J-curve. This review provided a basis for rational medication based on both two clinical evidences recently.
作者 郑刚
出处 《世界临床药物》 CAS 2010年第1期44-47,60,共5页 World Clinical Drug
关键词 降压治疗 J形曲线 高血压 死亡率 antihypertensive treatment J-curve hypertension mortality
  • 相关文献

参考文献1

  • 1Lennart Hansson. Antihypertensive Treatment: Does the J-curve Exist?[J] 2000,Cardiovascular Drugs and Therapy(4):367~372

同被引文献22

  • 1Cushman WC,Evans GW,Byington RP,et al.ACCORD Study Group.Effects of intensive blood-pressure control in type 2 diabetes mellitus.N Engl J Med,2010,362:1575-1585.
  • 2Bavry AA,Anderson RD,Gong Y,et al.Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease:findings from the INternational VErapamil-SR/Trandolapril STudy.Hypertension,2010,55:48-53.
  • 3Chan JC,Malik V,Jia W,et al.Diabetes in Asia:epidemiology,risk factors,and pathophysiology.JAMA,2009,301:2129-2140.
  • 4Yang W,Lu J,Weng J,et al.China national diabetes and metabolic disorders study group.Prevalence of diabetes among men and women in China.N Engl J Med,2010,362:1090-1101.
  • 5Holman RR,Haffner SM,McMurray JJ,et al.NAVIGATOR study group,effect of nateglinide on the incidence of diabetes and cardiovascular events.N Engl J Med,2010,362:1463-1476.
  • 6McMurray JJ,Holman RR,Haffner SM,et al.NAVIGATOR study greup,effect of valsartan on the incidence of diabetes and cardiovascular events.N Engl J Med,2010,362:1477-1490.
  • 7Nathan DM.Navigating the choices for diabetes prevention.N Engl J Med,2010,362:1533-1535.
  • 8Calles-Escand(o)n J,Lovato LC,Simons-Morton DG,et al.Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics:the ACCORD trial.Diabetes Care,2010,33:721-727.
  • 9Riddle MC,Ambresius WT,Brillon DJ,et al.Action to Central Cardiovascular Risk in Diabetes Investigators.Epidemiologlc relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.Diabetes Care,2010,33:983-990.
  • 10Bonds DE,Miller ME,Bergenstal RM,et al.The association between symptomatic,severe hypoglycaemia and mortality in type 2 diabetes:retrospective epidemiological analysis of the ACCORD study.BMJ,2010,340:b4909.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部